Hello, Fool! | Login | Signup | My Fool
Nov 19, 2008 10:29 AM ET | Feedback | Site Changes | Help
Operates in the business of patent-protected and generic pharmaceuticals as well as consumer health products.
View Ticker Page (NVS)
Results 11 - 20 of 150 : 12345Next »
Recs
theskyiscrape (62.60) Submitted: 1/29/07 9:16 PM : Start Price: $55.01 NVS Score: 28.14
great current product line; great pipeline; well-managed; deep cash pockets to fund both further acquisitions and biogenerics which WILL be approved for the USA, just a matter of time; the current budget deficits and mounting health care costs necess...
Report this Post Replies: 0 | Reply | Permalink
Oops! There appears to be a problem with your comment. Check to see if there's something you left out.
SorrySam (96.10) Submitted: 11/01/06 2:00 PM : Start Price: $57.87 NVS Score: 21.70
Strong drug pipeline, relatively cheap, and nvs also owns another company that specializes in the production of generic drugs.
sadiqpunjani (89.40) Submitted: 1/17/07 9:08 PM : Start Price: $55.55 NVS Score: 27.63
Novartis is a stable stock and they are highly diversified with four main business division- generic drugs, animal health, medical nutrition, Gerber & Ciba (contacts and solutions). Now they also have newly vaccines/preventive division. But the mos...
bizcbug7 (55.92) Submitted: 12/15/06 12:07 PM : Start Price: $55.84 NVS Score: 27.03
One of the best pipelines, a bunch of new drugs for osteopor., diabetes, hypetension. Patent expirations are few. Q sales growth & EPS growth greater than peers. Also has generics which should outgrow. Very little debt and lots of cash in pockets now...
daviddai (58.26) Submitted: 3/12/07 12:13 PM : Start Price: $54.71 NVS Score: 27.87
Leader in biotech innovation. Backed by its strong pipeline (the strongest among all other big pharmas), it has generated 11 billion in revenue in the last year. It has also hit jackpots after jackpots through acquisition of smaller firms that have...
Olya (28.24) Submitted: 12/27/06 8:37 PM : Start Price: $55.15 NVS Score: 27.95
I found this stock using MTF CAPS. This is my #2 use of CAPS (playing with 5 star rating stocks). CAPS likes it. Several good positive pitches. Not one negative pitch. Well-known foreign company that sells drugs. Steady growth. Small dividend. ...
nanwynnfan (53.76) Submitted: 4/18/08 2:51 PM : Start Price: $47.71 NVS Score: 40.33
Novartis is a drug giant with active interests in so many working partners that it doubles as a mutual fund. Its sheer size fixes profitability and P/E @ 14-15 times earnings; but a solid balance sheet and broad exposure to new product chains should...
NLP49 (92.89) Submitted: 7/25/08 7:03 PM : Start Price: $58.98 NVS Score: 13.69
Undervalued within its sector.
Craiger3 (< 20) Submitted: 7/31/08 2:58 PM : Start Price: $59.49 NVS Score: 14.39
A solid performer. BOT @ $47.50 in my brokerage account and will keep it for many years. Swiss Franc denominated, baby boomers get sick play, and a little dividend = reinvested.
corcione (60.23) Submitted: 4/05/08 6:05 AM : Start Price: $50.72 NVS Score: 33.70
Everyone seems to be talking about recession these days. Investing in pharmaceuticals, the question of whether or not you're in a recession just doesn't matter at all. The Swiss giant NVS is unbelievable cheap so that you're not paying for a quite go...
Terms & Conditions
RSS Headlines
Fool UK